Navigation Links
Milnacipran Demonstrated Significant Improvement in Pain and the Core Symptoms of Fibromyalgia Syndrome, Data Show
Date:11/8/2007

yl D- aspartate (NMDA)-receptor antagonist indicated for the treatment of moderate to severe Alzheimer's disease; and Campral(R)* (acamprosate calcium), indicated in combination with psychosocial support for the maintenance of abstinence from alcohol in patients with alcohol dependence who are abstinent at treatment initiation. In addition to our growing product line, Forest also co-promotes the Daiichi Sankyo, Inc. products Benicar(R)* (olmesartan medoxomil), an angiotensin receptor blocker, Benicar HCT(R)* (olmesartan medoxomil-hydrochlorothiazide), an angiotensin receptor blocker and diuretic combination product, and AZOR(TM)* (amlodipine and olmesartan medoxomil) a calcium channel blocker and angiotensin receptor blocker combination product, all indicated for the treatment of hypertension.

*Azor is a trademark of Daiichi Sankyo, Inc.; Benicar and Benicar HCT are registered trademarks of Daiichi Sankyo, Inc.; and Campral is a registered trademark of Merck Sante s.a.s., subsidiary of Merck KGaA, Darmstadt, Germany.

Except for the historical information contained herein, this release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve a number of risks and uncertainties, including the difficulty of predicting FDA approvals, the acceptance and demand for new pharmaceutical products, the impact of competitive products and pricing, the timely development and launch of new products, and the risk factors listed from time to time in the Forest Laboratories' SEC reports, including the Company's Annual Report on Form 10-K for the fiscal year ended March 31, 2007, and on Form 10-Q for the period ended June 30, 2007.


'/>"/>
SOURCE Forest Laboratories, Inc. and Cypress Bioscience, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Nebivolol Lowers Blood Pressure in Mild-to-Moderate Hypertensive Patients as Demonstrated in a Study Published in the Journal of Clinical Hypertension
2. Versatility of 454 Sequencing(TM) Demonstrated in Three Publications in Science Last Week
3. Clinical Benefits Demonstrated with Low-Dose GATTEX(TM) in Phase 3 Short Bowel Syndrome Study
4. Nebivolol Lowers Blood Pressure in African Americans With Stage I-II Hypertension as Demonstrated in a Study Published in the Journal of Clinical Hypertension
5. UPDATE: Nebivolol Lowers Blood Pressure in African Americans With Stage I-II Hypertension as Demonstrated in a Study Published in the Journal of Clinical Hypertension
6. Data Presented at the American Heart Association Scientific Sessions 2007 Demonstrated Increased HDL with ACTOS(R) (pioglitazone HCl) Slowed the Progression of Carotid Intima-Media Thickness in Patients with Type 2 Diabetes
7. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
8. DEFLUX(R) Significantly Reduces Urinary Tract Infections in Children With Vesicoureteral Reflux
9. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
10. Vidaza Significantly Extends Overall Survival by 74% in Phase 3 Trial in Myelodysplastic Syndromes (MDS)
11. Nexavar Significantly Improved Overall Survival in Phase 3 Asia-Pacific Liver Cancer Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... July 31, 2015  Boston Children,s Hospital physicians ... 3D printing of their anatomy before undergoing high-risk ... malformations (abnormalities in the brain,s blood vessels) that ... today in the Journal of Neurosurgery: Pediatrics ... printing and synthetic resins to create custom, high-fidelity ...
(Date:7/31/2015)... , July 31, 2015 According ... by Product (Moist Heat, Dry Heat, Ethylene Oxide, Filtration, E-beam, ... End User (Hospitals, Pharmaceuticals) - Global Forecast to 2020", published ... around USD 6.1 Billion by 2020, at a CAGR of ... 242 market data T ables and ...
(Date:7/31/2015)... 31, 2015  Xcelience, a contract development and ... made a structured cash investment in Powdersize, a ... milling, micronization and powder size classification within the ... business while simultaneously adding a complete set of ... capabilities. "As we continue to ...
Breaking Medicine Technology:3D Printing Helps Doctors Rehearse Complex Brain Procedures 23D Printing Helps Doctors Rehearse Complex Brain Procedures 33D Printing Helps Doctors Rehearse Complex Brain Procedures 4Sterilization Equipment Market is Expected to Reach USD 6.1 Billion by 2020 2Sterilization Equipment Market is Expected to Reach USD 6.1 Billion by 2020 3Sterilization Equipment Market is Expected to Reach USD 6.1 Billion by 2020 4Xcelience Makes Structured Cash Investment in Powdersize 2Xcelience Makes Structured Cash Investment in Powdersize 3
... key role in treatment discovery, MELBOURNE, Australia, ... Cytopia Limited (ASX: CYT) announced today that its ... in cells,isolated from patients with myeloproliferative disorders (MPDs)., ... there is over-production of,particular cells within the blood ...
... Tigris Pharmaceuticals,Inc., a privately held drug development company, ... study of aminoflavone,pro-drug (AFP-464) for the treatment of ... and enrollment is ongoing., The primary objectives ... limiting,toxicity (DLT) and maximum tolerated dose (MTD) of ...
Cached Medicine Technology:JAK2 Inhibitor Shows Potent Activity in Cells From MPD Patients 2Tigris Pharmaceuticals Initiates Phase I Study of AFP-464 in Patients with Solid Tumors 2Tigris Pharmaceuticals Initiates Phase I Study of AFP-464 in Patients with Solid Tumors 3
(Date:7/31/2015)... , ... July 31, 2015 , ... Like nearly every ... have also been advanced, upgraded, made more effective and less intrusive and painful. ... Medical Penile Enlargement Center. Dr. Loria currently stands as the only doctor in ...
(Date:7/31/2015)... ... July 31, 2015 , ... Recently, ZKB filed another ... Western Division (Case No. 3:15-cv-00397) involving the Implanon® contraceptive implant . , ... of their Implanon® implants, inability to locate the implants, unsuccessful and invasive attempts ...
(Date:7/31/2015)... ... July 31, 2015 , ... Successful ... DC, http://www.fdanews.com/importexportprogram , Having FDA-regulated products held at ports costs time, ... of risking containment — or even destruction — of products, an FDA insider ...
(Date:7/31/2015)... (PRWEB) , ... July 31, 2015 , ... The Heart ... patients don't experience angina until a heart rate of 150 beats versus 100 beats, ... in Calgary. "We are able to give life back to patients with heart disease," ...
(Date:7/31/2015)... and Rockport, ME (PRWEB) , ... July 31, 2015 , ... The alarm was ringing. ... , Glancing out of the window, he recalled that his equipment was set up ... Street tower, he jumped out of bed. , The photo speaks for itself. Chatfield ...
Breaking Medicine News(10 mins):Health News:Loria Medical Penile Enlargement Center to Expand, Offering Practice Partnership to Doctors 2Health News:Can Implanon® (Etonogestrel Implant) Go Missing? Zoll, Kranz & Borgess, LLC Files Another Lawsuit on Behalf of Women with Lost or Migrated Implanon® Implants 2Health News:Can Implanon® (Etonogestrel Implant) Go Missing? Zoll, Kranz & Borgess, LLC Files Another Lawsuit on Behalf of Women with Lost or Migrated Implanon® Implants 3Health News:FDAnews Announces — Successful Import/Export Programs: Former FDA Expert Shows the Way, Oct. 20-21, 2015 2Health News:FDAnews Announces — Successful Import/Export Programs: Former FDA Expert Shows the Way, Oct. 20-21, 2015 3Health News:FDAnews Announces — Successful Import/Export Programs: Former FDA Expert Shows the Way, Oct. 20-21, 2015 4Health News:Heart Fit Clinic Helps Patient Increase Fitness Level with External Counterpulsation 2
... PORTLAND, Ore., Oct. 20 When Regence member Adrianne Johnson ... friends for recommendations, and then logged on to myRegence.com to ... were patients of those doctors. Based on the Member Reviews ... just a PCP she was comfortable with, but specialists, as ...
... Oct. 20 /PRNewswire-FirstCall/ - MDS Inc. (TSX: MDS; NYSE: ... the global life sciences markets, today announced that Company shareholders ... a leading global supplier of drug discovery and life sciences ... in cash. , A Special Meeting of Shareholders was held ...
... Speaker Nancy Pelosi, House Majority Leader Steny Hoyer, ... held a press availability this afternoon in the Capitol with ... insurance reform for children with pre-existing conditions. Shannon Saunders Eaton ... Texas told their personal stories as ...
... Oct. 20 Justin Timberlake; Sam, Younes and David Nazarian; ... Cedars-Sinai Board of Governors at their annual Gala on ... in Los Angeles, California. The event, sponsored by Lexus, ... As the event sponsor, Lexus donated a 2010 Lexus LS ...
... prostate cancer the most diagnosed cancer for women and ... from these diseases, argue experts from the University of California, ... at San Antonio in an opinion piece published in the ... overall cancer rates are higher, many more patients are being ...
... ... Information and Support , ... Philadelphia, PA (Vocus) October 20, 2009 -- Keystone Mercy Health Plan, the largest ... mammography and pap smear exams, to more than 2,100 women through its Gift for ...
Cached Medicine News:Health News:Regence Takes Community Approach to Provider 'Reviews' 2Health News:Regence Takes Community Approach to Provider 'Reviews' 3Health News:MDS Inc. Announces Shareholder Approval of Sale of MDS Analytical Technologies 2Health News:MDS Inc. Announces Shareholder Approval of Sale of MDS Analytical Technologies 3Health News:Pelosi Remarks at Press Availability with Easter Seals on Benefits of Health Reform for Children 2Health News:Pelosi Remarks at Press Availability with Easter Seals on Benefits of Health Reform for Children 3Health News:Justin Timberlake, Sam Nazarian, Younes Nazarian, David Nazarian, Larry and Sandy Post to Be Honored at 2009 Cedars-Sinai Board of Governors Gala Sponsored By Lexus 2Health News:Experts issue call to reconsider screening for breast cancer and prostate cancer 2Health News:Experts issue call to reconsider screening for breast cancer and prostate cancer 3Health News:Experts issue call to reconsider screening for breast cancer and prostate cancer 4Health News:Experts issue call to reconsider screening for breast cancer and prostate cancer 5Health News:Keystone Mercy Health Plan Initiative Brings Cancer Screenings to Underserved Women in Their Communities 2Health News:Keystone Mercy Health Plan Initiative Brings Cancer Screenings to Underserved Women in Their Communities 3Health News:Keystone Mercy Health Plan Initiative Brings Cancer Screenings to Underserved Women in Their Communities 4
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: